Treatment and Trial Options
Clinical trials are research studies that involve people. Any time you or a loved one need treatment for cancer, clinical trials are an option to think about. Learning all you can about clinical trials can help you talk with your doctor and decide what is right for you.
We want to provide you with up-to-date, credible information about clinical trials. Information on this page is from the National Cancer Institute (NCI) and the National Institutes of Health (NIH).
Making your personalized care plan
Your doctors will help you make the plan that is best for you based on a good evaluation of your cancer, your general health and your preferences.
Understanding more about the treatment options, both the surgical and drug treatment options that may be discussed, will help you during your initial appointments.
For some patients the only treatment they need is surgery. For others, surgery is not suggested for the treatment plan. The test information will guide the discussion but this short video for kidney cancer is a must watch before your consultations with the urologist and urologic surgeon.
Active Surveillance: Is it safe to watch small renal masses?
“Active Surveillance” is sometimes mentioned as an option especially for a small mass. Two informative videos are provided for patients considering “Active Surveillance”.
Can you explain nephrectomy?
Dr. Eric Kauffman, MD, discusses the difference between partial and radical nephrectomy of kidney cancer.
What are histology and grade and stage of my kidney cancer? Why are they important?
The report on your biospy or nephrectomy contains important information on the type and stage of your cancer. Click to view this handout from IKCC which gives you the basics on how your testing may guide your care plan.
Understanding your pathology report: for clear cell, papillary and chromophobe subtypes
Clear Cell Renal Carcinoma
Clear cell renal cell carcinoma is the most common type of kidney cancer in adults.
Papillary renal cell carcinoma
Papillary renal cell carcinoma is the second most common type of kidney cancer in adults.
chromophobe renal cell carcinoma
Chromophobe renal cell carcinoma is the third most common type of kidney cancer in adults.
Reliable Resources for Cancer Information
NATIONAL CANCER INSTITUTE
INTERNATIONAL KIDNEY CANCER COALITION
CANCER AND CAREERS
WHO WE ARE →
WHAT WE DO →
OUR STORIES →
THE KIDNEY CANCER COMMUNITY →
SCIENTIFIC ADVISORS →
Scarlett Talcott, a vibrant 11-year-old from southern Montana, stands confidently in front of the Capitol Building during KidneyCAN's Advocacy Day. Living on a ranch with her parents, sister, and two brothers, Scarlett balances her love for the arts, crafting, and 4-H activities with a strong...
SPRING ADVOCACY DAYS 2024 →
JOIN OUR COMMUNITY →
RAISING AWARENESS →
BE AN ADVOCATE →
DONATE NOW →
UNDERSTANDING YOUR KIDNEY CANCER DIAGNOSIS
BUILDING YOUR CARE TEAM
TREATMENT & TRIAL OPTIONS
KIDNEY CANCER & THE MILITARY
CLINICAL TRIALS →
RESEARCH UPDATES →
OPTIMIZING YOUR KIDNEY HEALTH →
HANDLING HOLIDAYS WITH CANCER →
KCRS: KIDNEY CANCER RESEARCH SUMMIT →
RESEARCH OPPORTUNITIES →
For this Community Spotlight feature, we spoke to Dr. Yousef Zakharia, a medical oncologist at the Holden Comprehensive Cancer Center and associate professor at the University of Iowa. Dr. Zakharia shares important information about finding the best care at NCI-designated centers, as well as his...
SUPPORT OUR WORK →
ROCK THE RUN 2023 →
FUNDRAISE FOR KIDNEYCAN →
On the outskirts of Tulsa, Oklahoma, Maggie Burns stands as a testament to resilience and advocacy within the kidney cancer community. A caregiver to her husband, Ron Stanton, Maggie is a proud member of the Cherokee Nation and a retired IT professional. Maggie's life is a rich tapestry of...